Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 December 2020
Health sciences
The more than 100 medical students who graduated virtually from the University of the Free State (UFS) Faculty of Health Sciences on Monday (14 December), graduated with a pass rate of 98% in a tumultuous year dominated by the COVID-19 pandemic. The MB ChB class of 2020 – a total of 104 students from the School of Clinical Medicine – graduated virtually on Monday due to COVID-19.

The more than 100 medical students who graduated virtually from the University of the Free State (UFS) Faculty of Health Sciences on Monday (14 December), graduated with a pass rate of 98% in a tumultuous year dominated by the COVID-19 pandemic.

The MB ChB class of 2020 – a total of 104 students from the School of Clinical Medicine – graduated virtually on 14 December due to COVID-19. Another virtual graduation is scheduled for 4 January 2021.

An uncomfortable reality
Dr Lynette van der Merwe, undergraduate medical programme director in the School of Clinical Medicine at the UFS, congratulated the latest UFS doctors on their success. Said Dr Van der Merwe: “In a tumultuous year dominated by the COVID-19 pandemic, this group of final-year medical students refused to give in to the pressure and disruption of national lockdown, emergency remote teaching, an adjusted academic calendar, and frontline exposure as healthcare professionals in training.”  

“They persevered against all odds, faced up to an uncomfortable reality, and showed remarkable resilience.”

According to Dr Van der Merwe, the class of 2020 completed the gruelling five-year medical programme with a pass rate of 98,3%, impressing external examiners who commented on their respectful attitude towards patients and thorough knowledge and skill.  

“The School of Clinical Medicine and Faculty of Health Sciences are immensely proud of our new colleagues and look forward to their contribution to the future of healthcare in South Africa. This achievement would not have been possible without the unwavering commitment of the academic and support staff who guided our students and led the way for them to achieve a life-long dream.”  

“We look back with gratitude on a year that required more than the usual amount of adaptability, creativity, innovation, faith, patience, bravery, and endurance.  It is these qualities that set apart the doctors who graduate from the UFS, and those who train them,” says Dr Van der Merwe.

Hope for the future
She says while COVID-19 is still a harsh reality and the future holds much uncertainty, 2020 has shown that there is hope when we face challenges with grace under pressure, and a firm belief in our goals and values. “Class of 2020, may you continue to rise above fear, chaos and disappointment, may you take heart and walk your journey with strength, may you bring healing to our people and lead us well.”

Drs Kaamilah Joosub and Lynette Upman, who also graduated on Monday, were awarded the prestigious Bongani Mayosi Medical Students Academic Prize – a national award which aims to recognise final-year medical students who epitomise the academic, legendary, and altruistic life of the late Prof Mayosi. The awards are presented to final-year MB ChB students from all South African medical faculties. This is the first year it has been awarded.

View the virtual graduation

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept